PHI with Chronic ulcerative proctosigmoiditis
How does this condition affect your private health insurance?
Chronische ulzeröse Proktosigmoiditis is a chronic inflammatory bowel disease, a form of ulcerative colitis, specifically affecting the rectum and sigmoid colon. It's characterized by continuous inflammation and ulcers in the innermost lining of these segments. Symptoms typically include bloody diarrhea, urgency, tenesmus (feeling of incomplete defecation), and mild abdominal discomfort. While often less severe than extensive colitis, it can significantly impact quality of life through recurrent flares. The condition is lifelong, requiring ongoing management to induce and maintain remission, primarily with topical or oral aminosalicylates. Regular monitoring is essential.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months for an initial flare-up
Duration of Illness (Lifetime)
Chronic, lifelong with periods of remission and flare-ups
Cost of Treatment (Initial)
Moderate (e.g., several thousand USD for diagnosis, medication, and initial management)
Cost of Treatment (Lifetime)
High to very high (e.g., tens to hundreds of thousands USD, depending on disease progression, need for advanced therapies, and monitoring)
Mortality Rate
Low directly from proctosigmoiditis itself; increased risk with severe complications like toxic megacolon or long-term extensive disease leading to colorectal cancer, but generally <1% for limited disease
Risk of Secondary Damages
Moderate to high (e.g., anemia, psychological distress, extra-intestinal manifestations like arthritis, increased risk of colorectal cancer if disease extends or is long-standing)
Probability of Full Recovery
Very low (generally considered a lifelong chronic disease; sustained remission is the treatment goal, not a cure without consequences)
Underlying Disease Risk
Low to moderate (other autoimmune conditions can co-occur but are not typically primary underlying diseases at onset; genetic predispositions exist)